Fibroblast as a critical stromal cell type determining prognosis in prostate cancer-Reference-Cited by-同舟云学术

Fibroblast as a critical stromal cell type determining prognosis in prostate cancer

Author:

Blom Sami¹,Erickson Andrew¹,Östman Arne²,Rannikko Antti³,Mirtti Tuomas⁴,Kallioniemi Olli¹²,Pellinen Teijo¹^ORCID

Affiliation:

1. Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE) University of Helsinki Helsinki Finland

2. Science for Life Laboratory, Department of Oncology and Pathology Karolinska Institutet Stockholm Sweden

3. Department of Urology Helsinki University and Helsinki University Hospital Helsinki Finland

4. Department of Pathology University of Helsinki Helsinki Finland

Funder

Terveyden Tutkimuksen Toimikunta

Helsingin ja Uudenmaan Sairaanhoitopiiri

Publisher

Wiley

Subject

Urology,Oncology

Link

Reference29 articles.

1. Ervik M Lam F Ferlay J Mery L Soerjomataram I Bray F. Cancer Today. Lyon France: International Agency for Research on Cancer; 2016.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献